Search clinical trials for: Cisplatin and Pemetrexed
Total 271391 results
-
CanBas Co. Ltd.CompletedSolid Tumors | Malignant Pleural MesotheliomaUnited States
-
CanBas Co. Ltd.CompletedMetastatic Non-squamous Non Small Cell Lung CancerUnited States
-
Guangzhou Medical UniversityUnknownNon Small Cell Lung CancerChina
-
BayerTerminated
-
BeiGeneCompletedNon-Small Cell Lung CancerChina
-
Sun Yat-sen UniversityRecruitingCarcinoma，Non-Small-Cell LungChina
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerCanada
-
Yonsei UniversityActive, not recruitingSarcomaKorea, Republic of
-
Eli Lilly and CompanyCompletedGastrointestinal NeoplasmsKorea, Republic of
-
Yonsei UniversityRecruiting
-
Eli Lilly and CompanyCompletedMalignant Pleural MesotheliomaJapan
-
Shanghai Chest HospitalCompletedLung Adenocarcinoma | EGFR Activating Mutation
-
PfizerCompletedNSCLC (Non-small Cell Lung Cancer)Hong Kong, China, Taiwan, Malaysia, Thailand
-
University of KansasMerck Sharp & Dohme LLCCompletedNon Small Cell Lung CancerUnited States
-
Sun Yat-sen UniversityUnknownBevacizumab | Brain Metastases | Non Squamous Non-small Cell Lung CancerChina
-
Shanghai Zhongshan HospitalNot yet recruiting
-
Eli Lilly and CompanyTerminated
-
Eli Lilly and CompanyCompletedPleural NeoplasmsUnited States
-
Cancer Institute and Hospital, Chinese Academy...CompletedLocally Advanced Malignant NeoplasmChina
-
Eli Lilly and CompanyCompletedNeoplasm, GastricTaiwan, Argentina, Mexico, Korea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedCervical CancerUnited States
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced or Metastatic Non-squamous Non-small-cell Lung Cancer
-
Eli Lilly and CompanyTerminatedSmall Cell Lung Cancer | SCLC | Carcinoma, Small CellNetherlands, Belgium
-
Shantou University Medical CollegeUnknownPleural Effusion, MalignantChina
-
Fudan UniversityUnknownLocal Advanced Non-Small Cell Lung CancerChina
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellDenmark, United Kingdom
-
Eli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedGastric CancerRussian Federation
-
University of Southern CaliforniaSponsor Name PendingWithdrawn
-
Intergroupe Francophone de Cancerologie ThoraciqueUniversity Hospital, Caen; Groupe Français de Pneumo-CancérologieCompleted
-
Sichuan UniversityChia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedNon-squamous Non-small-cell Lung Cancer | AnlotinibChina
-
Li Zhang, MDRecruitingCarcinoma, Non-Small-Cell LungChina
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Pleural MesotheliomaBelgium, Netherlands
-
University of ArizonaNational Cancer Institute (NCI)CompletedEsophageal CancerUnited States
-
Universität Duisburg-EssenEli Lilly and CompanyUnknown
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
University Hospital, BrestCompleted
-
Memorial Sloan Kettering Cancer CenterWithdrawnMalignant Pleural MesotheliomaUnited States
-
UNICANCERCompletedMetastatic Cancer | Solid TumorsFrance
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingMesothelioma, Malignant | Mesothelioma, Malignant Pleural | Mesothelioma Malignant AdvancedChina
-
Innovent Biologics (Suzhou) Co. Ltd.Not yet recruitingNon-squamous Non-small-cell Lung CancerChina
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer NSCLCPoland, United States, Taiwan, Thailand, Vietnam, Korea, Republic of, United Kingdom, Brazil, Hungary, Japan, Mexico, Peru, Russian Federation, China, Germany, South Africa, Ukraine, Bulgaria, Hong Kong
-
European Organisation for Research and Treatment...Terminated
-
Innate PharmaRecruitingNon Small Cell Lung CancerFrance, United States, Greece, Hungary, Poland
-
Spanish Lung Cancer GroupTerminatedCarcinoma, Non Small Cell LungSpain
-
University Hospital, AntwerpEli Lilly and Company; Universiteit AntwerpenCompleted
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.UnknownApatinib Combine With Platinum-Based Doublet Chemotherapy for First-line Treatment of Advanced NSCLCLung Cancer | Non Small Cell Lung Cancer | Apatinib | Combination ChemotherapyChina
-
Roswell Park Cancer InstituteCompleted
-
Guangzhou Medical UniversityCompletedLung Adenocarcinoma | Brain MetastasesChina